Brain bleeding in premature babies
Part of Brain & nervous system clinical trials.
This study looks at premature babies who are born very early and weigh very little, to understand bleeding in the brain (called intraventricular hemorrhage). If your baby is eligible, the research may help doctors learn more about this condition and how to manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born before 34 weeks of pregnancy
- Weighed less than 1500 grams (about 3 pounds 5 ounces) at birth
- Admitted to the NICU within the first 24 hours after birth
- No major birth defects, especially brain or spinal cord abnormalities
- No severe lack of oxygen during birth (perinatal asphyxia)
- No infections passed from mother to baby at birth (like TORCH infections)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to prevent, find early, and manage bleeding in the brain and the fluid buildup that can follow in premature babies. If your baby had such bleeding and fluid buildup, the study may offer close monitoring and care to help improve outcomes.
This trial tests a light therapy device in newborns who had a severe form of brain bleeding (intraventricular hemorrhage grade 3 or 4) within the first month of life. The goal is to see if this non-invasive treatment may help improve recovery.
This Phase 1 trial studies whether giving erythropoietin (EPO) and melatonin is safe in very preterm infants who have bleeding in the brain (intraventricular hemorrhage) or significant nearby brain injury. It aims to see if these medicines can be given safely during the early days after birth.
This study follows newborns and premature babies who had bleeding in the brain (intra-cranial or within the brain’s fluid spaces). It looks at long-term outcomes to better understand what happens over time and support families with care planning.
This study looks at using two noninvasive tools on very preterm newborns to better predict whether an intraventricular hemorrhage (bleeding in the brain’s fluid spaces) may happen. If successful, it could help doctors spot risk earlier and monitor or treat babies sooner.
This study tests if giving a single dose of a medicine called indomethacin to very premature babies can help prevent bleeding in the brain. The medicine is given soon after birth to babies born before 26 weeks of pregnancy or weighing less than 750 grams.
Hear when a new Intraventricular Hemorrhage of Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.